Kouhei Nakachi

Primary Tumor of Pancreatic Cancer as a Measurable Target Lesion in Chemotherapy Trials (2005)

Ishii, Hiroshi, Furuse, Junji, Nakachi, Kouhei, Suzuki, Ei-ichiro, Yoshino, Masahiro

Background: It is unclear whether primary pancreatic cancer (PC) tumors can be accepted as measurable target lesions in chemotherapy trials. We reviewed recent PC patients to clarify the significance...

Treatment Cost of Pancreatic Cancer in Japan: Analysis of the Difference after the Introduction of Gemcitabine (2005)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: Recent advances in cancer chemotherapy have increased not only the survival rate but also the treatment cost, although there has been little interest in cost analyses in Japan. Method:...

Primary Tumor of Pancreatic Cancer as a Measurable Target Lesion in Chemotherapy Trials (2005)

Ishii, Hiroshi, Furuse, Junji, Nakachi, Kouhei, Suzuki, Ei-ichiro, Yoshino, Masahiro

Background: It is unclear whether primary pancreatic cancer (PC) tumors can be accepted as measurable target lesions in chemotherapy trials. We reviewed recent PC patients to clarify the significance...

Treatment Cost of Pancreatic Cancer in Japan: Analysis of the Difference after the Introduction of Gemcitabine (2005)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: Recent advances in cancer chemotherapy have increased not only the survival rate but also the treatment cost, although there has been little interest in cost analyses in Japan. Method:...

Treatment Cost of Pancreatic Cancer in Japan: Analysis of the Difference after the Introduction of Gemcitabine (2005)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: Recent advances in cancer chemotherapy have increased not only the survival rate but also the treatment cost, although there has been little interest in cost analyses in Japan. Method:...

Primary Tumor of Pancreatic Cancer as a Measurable Target Lesion in Chemotherapy Trials (2005)

Ishii, Hiroshi, Furuse, Junji, Nakachi, Kouhei, Suzuki, Ei-ichiro, Yoshino, Masahiro

Background: It is unclear whether primary pancreatic cancer (PC) tumors can be accepted as measurable target lesions in chemotherapy trials. We reviewed recent PC patients to clarify the significance...

Extrahepatic Spread from Hepatocellular Carcinoma: Who are Candidates for Aggressive Anti-cancer Treatment? (2004)

Ishii, Hiroshi, Furuse, Junji, Kinoshita, Taira, Konishi, Masaru, Nakagohri, Toshio, Takahashi, Shinichiro, ...

Background: There is no standard treatment for patients with extrahepatic spread from hepatocellular carcinoma. The aim of this retrospective study was to identify candidates for aggressive...